Gerald R. Ewoldt

Array ( [id] => 6882458 [patent_doc_number] => 20010048930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'Methods of immunosuppression' [patent_app_type] => new [patent_app_number] => 09/870902 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9915 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20010048930.pdf [firstpage_image] =>[orig_patent_app_number] => 09870902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032912 [patent_doc_number] => 20020019048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Methods for restoring or enhancing T-cell immune surveillance following naturally or artificially induced immunosuppression' [patent_app_type] => new [patent_app_number] => 09/864930 [patent_app_country] => US [patent_app_date] => 2001-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9661 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019048.pdf [firstpage_image] =>[orig_patent_app_number] => 09864930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7078201 [patent_doc_number] => 20010041179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'CD25 binding molecules for use in the treatment of manifestations of rejection in transplantation' [patent_app_type] => new [patent_app_number] => 09/862212 [patent_app_country] => US [patent_app_date] => 2001-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2490 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041179.pdf [firstpage_image] =>[orig_patent_app_number] => 09862212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6921394 [patent_doc_number] => 20010028879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'Inhibition of graft versus host disease' [patent_app_type] => new [patent_app_number] => 09/853755 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4349 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20010028879.pdf [firstpage_image] =>[orig_patent_app_number] => 09853755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796374 [patent_doc_number] => 20030175247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Method to increase class I presentation of exogenous antigens by human dendritic cells' [patent_app_type] => new [patent_app_number] => 09/854248 [patent_app_country] => US [patent_app_date] => 2001-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13827 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175247.pdf [firstpage_image] =>[orig_patent_app_number] => 09854248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7679150 [patent_doc_number] => 20030167502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Human monoclonal antibodies to dendritic cells' [patent_app_type] => new [patent_app_number] => 09/851614 [patent_app_country] => US [patent_app_date] => 2001-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27910 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20030167502.pdf [firstpage_image] =>[orig_patent_app_number] => 09851614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861169 [patent_doc_number] => 20030092177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Method for generating highly active human dendritic cells from monocytes' [patent_app_type] => new [patent_app_number] => 09/845042 [patent_app_country] => US [patent_app_date] => 2001-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13545 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092177.pdf [firstpage_image] =>[orig_patent_app_number] => 09845042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6470983 [patent_doc_number] => 20020022030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-21 [patent_title] => 'Product and process for regulation of T cell responses' [patent_app_type] => new [patent_app_number] => 09/844928 [patent_app_country] => US [patent_app_date] => 2001-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22566 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20020022030.pdf [firstpage_image] =>[orig_patent_app_number] => 09844928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887936 [patent_doc_number] => 20020012667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Method for preventing allograft rejection' [patent_app_type] => new [patent_app_number] => 09/834450 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4017 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20020012667.pdf [firstpage_image] =>[orig_patent_app_number] => 09834450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289198 [patent_doc_number] => 20020054872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Peptides for the treatment of systemic lupus erythematosus and methods of treating systemic lupus erythematosus' [patent_app_type] => new [patent_app_number] => 09/826069 [patent_app_country] => US [patent_app_date] => 2001-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5164 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20020054872.pdf [firstpage_image] =>[orig_patent_app_number] => 09826069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6951778 [patent_doc_number] => 20050226872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Use of cd25 binding molecules in the treatmnet of inflammatory diseases of the gastrointestinal tract' [patent_app_type] => utility [patent_app_number] => 10/240353 [patent_app_country] => US [patent_app_date] => 2001-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3676 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226872.pdf [firstpage_image] =>[orig_patent_app_number] => 10240353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6889190 [patent_doc_number] => 20010024645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation' [patent_app_type] => new [patent_app_number] => 09/810999 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15128 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20010024645.pdf [firstpage_image] =>[orig_patent_app_number] => 09810999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6889190 [patent_doc_number] => 20010024645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation' [patent_app_type] => new [patent_app_number] => 09/810999 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15128 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20010024645.pdf [firstpage_image] =>[orig_patent_app_number] => 09810999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843441 [patent_doc_number] => 20020131953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'In situ langerhans cell vaccine' [patent_app_type] => new [patent_app_number] => 09/808555 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10536 [patent_no_of_claims] => 132 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20020131953.pdf [firstpage_image] =>[orig_patent_app_number] => 09808555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6986832 [patent_doc_number] => 20010036664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'L-leucyl-L-leucine methyl ester treatment of donor lypmhocyte infusions in bone marrow transplant patients' [patent_app_type] => new [patent_app_number] => 09/803223 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3509 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036664.pdf [firstpage_image] =>[orig_patent_app_number] => 09803223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6961266 [patent_doc_number] => 20010012632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-09 [patent_title] => 'Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response' [patent_app_type] => new [patent_app_number] => 09/802397 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17995 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20010012632.pdf [firstpage_image] =>[orig_patent_app_number] => 09802397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674249 [patent_doc_number] => 20030059852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Modulation of integrin-mediated signal transduction' [patent_app_type] => new [patent_app_number] => 09/801089 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18938 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059852.pdf [firstpage_image] =>[orig_patent_app_number] => 09801089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859140 [patent_doc_number] => 20020123140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'In vitro method to generate dendritic langerhans type cells' [patent_app_type] => new [patent_app_number] => 09/800448 [patent_app_country] => US [patent_app_date] => 2001-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2882 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123140.pdf [firstpage_image] =>[orig_patent_app_number] => 09800448 [rel_patent_id] =>[rel_patent_doc_number] =>)